mitoxantrone has been researched along with Paraplegia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakhani, AK | 1 |
| Zuiable, AG | 1 |
| Pollard, CM | 1 |
| Milne, A | 1 |
| Treleaven, J | 1 |
| Powles, RL | 1 |
1 other study available for mitoxantrone and Paraplegia
| Article | Year |
|---|---|
Paraplegia after intrathecal mitozantrone.
Topics: Adult; Antineoplastic Agents; Central Nervous System Diseases; Humans; Injections, Spinal; Leukemia, | 1986 |